Recently, the team of Chen Qingan, a researcher at the Dalian Institute of Chemical Physics, Chinese Academy of Sciences, has made new progress in the reuse of halogenated organic pollutants. They developed a bromide-catalyzed chlorine transfer reaction that can utilize halogenated organic pollutants as halogen sources to achieve the reuse of different

Founded in 1970 and listed on the Shanghai Stock Exchange in 2000, Hengrui Medicine is an innovative international pharmaceutical enterprise focusing on the research, development, production and promotion of high-quality drugs, focusing on the research and development of new drugs in the fields of anti-tumor, metabolic diseases, autoimmune diseases, respiratory diseases, neurological diseases and other areas, and it is one of the most innovative pharmaceutical leading enterprises in China.

The Chinese Academy of Sciences (CAS) has put forward the concept of building a national innovation system, and has successively implemented the Knowledge Innovation Project, Innovation 2020, the Pioneering Action Program and the Outline of Comprehensive and Deepening Reform, and put forward strategic research reports, such as “Embracing the Age of Knowledge Economy, and Building a National Innovation System Innovation for Development, Science and Technology Leading the Future, Innovation 2050: Science and Technology and China's Future, New Situation of Scientific and Technological Development and Strategic Choices for 2020, and other strategic research reports.

Bristol-Myers is a global biotechnology company focused on the development and commercialization of innovative, affordable antineoplastic drugs with the goal of improving treatment outcomes and access to medicines for patients worldwide.